Pursuant to a congressional request, GAO reviewed the procurement and modification of aircraft and other equipment used for drug detection and monitoring, focusing on: (1) whether equipment acquisitions met the Department of Defense's (DOD), the U.S. Customs Service's, and the U.S. Coast Guard's legitimate requirements; and (2) whether the agencies coordinated their acquisitions.
Recommendations for Executive Action
|Office of National Drug Control Policy||To prevent counterdrug funds from being spent unnecessarily on acquisition of detection and monitoring equipment, the Director, ONDCP, should certify that: (1) budget requests to acquire detection and monitoring equipment are based on valid requirements derived from the national drug-threat assessment; and (2) the requirements cannot be met with existing or planned resources in the federal inventory. This certification process should employ, to the extent practicable, the coordination mechanisms already in place via various interagency committees.|
|Department of Defense||The DOD Coordinator for Drug Enforcement Policy and Support should disapprove all future requests for counterdrug funds for the UC-26C program unless a valid counterdrug requirement for the aircraft is established and the Coordinator's office verifies that the requirement cannot be met with existing or planned assets of either DOD or another interdiction agency.|
|National Guard Bureau||The Chief of the National Guard Bureau and the Commandant of the Coast Guard should declare, respectively, the UC-26C and the EC-130V aircraft excess unless a validated requirement is established.|
|United States Coast Guard||The Chief of the National Guard Bureau and the Commandant of the Coast Guard should declare, respectively, the UC-26C and the EC-130V aircraft excess unless a validated requirement is established.|